This company has been marked as potentially delisted and may not be actively trading. CAMP4 Therapeutics (CAMP) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSustainabilityTrendsBuy This Stock CAMP vs. KVHI, CMTL, AWRE, CSCO, QCOM, PANW, MSI, FFIV, JNPR, and CIENShould you be buying CAMP4 Therapeutics stock or one of its competitors? The main competitors of CAMP4 Therapeutics include KVH Industries (KVHI), Comtech Telecommunications (CMTL), Aware (AWRE), Cisco Systems (CSCO), QUALCOMM (QCOM), Palo Alto Networks (PANW), Motorola Solutions (MSI), F5 (FFIV), Juniper Networks (JNPR), and Ciena (CIEN). These companies are all part of the "communications equipment" industry. CAMP4 Therapeutics vs. Its Competitors KVH Industries Comtech Telecommunications Aware Cisco Systems QUALCOMM Palo Alto Networks Motorola Solutions F5 Juniper Networks Ciena CAMP4 Therapeutics (NASDAQ:CAMP) and KVH Industries (NASDAQ:KVHI) are both small-cap communications equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, media sentiment and institutional ownership. Does the media prefer CAMP or KVHI? In the previous week, KVH Industries had 1 more articles in the media than CAMP4 Therapeutics. MarketBeat recorded 1 mentions for KVH Industries and 0 mentions for CAMP4 Therapeutics. KVH Industries' average media sentiment score of 0.67 beat CAMP4 Therapeutics' score of 0.00 indicating that KVH Industries is being referred to more favorably in the news media. Company Overall Sentiment CAMP4 Therapeutics Neutral KVH Industries Positive Do institutionals & insiders hold more shares of CAMP or KVHI? 73.7% of KVH Industries shares are held by institutional investors. 33.6% of CAMP4 Therapeutics shares are held by company insiders. Comparatively, 21.1% of KVH Industries shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has higher valuation & earnings, CAMP or KVHI? KVH Industries has higher revenue and earnings than CAMP4 Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCAMP4 Therapeutics$650K46.24-$51.79MN/AN/AKVH Industries$113.83M0.93-$11.05M-$0.49-11.06 Do analysts recommend CAMP or KVHI? CAMP4 Therapeutics presently has a consensus target price of $16.50, indicating a potential upside of 1,006.64%. Given CAMP4 Therapeutics' stronger consensus rating and higher possible upside, equities analysts clearly believe CAMP4 Therapeutics is more favorable than KVH Industries.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CAMP4 Therapeutics 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.17KVH Industries 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is CAMP or KVHI more profitable? CAMP4 Therapeutics has a net margin of 0.00% compared to KVH Industries' net margin of -8.72%. CAMP4 Therapeutics' return on equity of 0.00% beat KVH Industries' return on equity.Company Net Margins Return on Equity Return on Assets CAMP4 TherapeuticsN/A N/A N/A KVH Industries -8.72%-4.47%-3.91% SummaryCAMP4 Therapeutics beats KVH Industries on 9 of the 14 factors compared between the two stocks. Get CAMP4 Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CAMP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CAMP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CAMP vs. The Competition Export to ExcelMetricCAMP4 TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$29.23M$2.96B$5.57B$9.02BDividend YieldN/A2.44%5.25%4.03%P/E RatioN/A21.1627.2120.15Price / Sales46.24260.59416.26185.35Price / CashN/A41.8337.0657.97Price / Book0.487.768.085.60Net Income-$51.79M-$54.96M$3.16B$248.50M CAMP4 Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CAMPCAMP4 Therapeutics3.1189 of 5 stars$1.49-60.1%$16.50+1,006.6%+282.5%$29.23M$650K0.00644Gap UpKVHIKVH Industries1.3325 of 5 stars$5.38-0.6%N/A+22.2%$106.03M$113.83M-10.98650CMTLComtech Telecommunications3.7104 of 5 stars$2.50-3.8%$6.00+140.0%-6.6%$76.43M$495.35M-0.251,990AWREAware0.7166 of 5 stars$1.83flatN/A+9.0%$38.60M$17.39M-7.3280CSCOCisco Systems4.7418 of 5 stars$68.93-0.6%$69.53+0.9%+51.2%$274.71B$53.80B28.1390,400Positive NewsAnalyst ForecastQCOMQUALCOMM4.9236 of 5 stars$158.09-2.5%$188.00+18.9%-23.1%$178.11B$38.96B16.1049,000Positive NewsAnalyst ForecastPANWPalo Alto Networks4.4856 of 5 stars$201.42-0.2%$208.00+3.3%+22.6%$134.57B$8.03B115.1015,289Positive NewsInsider TradeMSIMotorola Solutions4.8196 of 5 stars$426.20+0.3%$513.25+20.4%+7.0%$70.91B$10.96B35.5821,000Positive NewsAnalyst ForecastFFIVF54.0124 of 5 stars$299.26-0.3%$282.56-5.6%+76.2%$17.24B$2.82B28.396,557Positive NewsAnalyst ForecastJNPRJuniper Networks3.3779 of 5 stars$39.95flat$40.00+0.1%N/A$13.36B$5.20B38.053,519CIENCiena4.1551 of 5 stars$80.11-1.6%$84.31+5.2%+70.0%$11.50B$4.01B111.268,657Analyst Upgrade Related Companies and Tools Related Companies KVHI Competitors CMTL Competitors AWRE Competitors CSCO Competitors QCOM Competitors PANW Competitors MSI Competitors FFIV Competitors JNPR Competitors CIEN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CAMP) was last updated on 7/10/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredHow a Kansas farm boy gained 1,285% in two daysA former farm kid placed a simple trade… and cashed out a 1,285% gain two days later. It wasn’t crypto or a...TradeSmith | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting—or plan to collect—Social Security, this could be a game-changer. A new initiative tie...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CAMP4 Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CAMP4 Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
